Chimerix logo

Chimerix share price today

(CMRX)

Chimerix share price is $3.34 & ₹284.56 as on 25 Dec 2024, 2.30 'hrs' IST

$3.34

0.32

(10.6%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Chimerix share price in Dollar and Rupees. Guide to invest in Chimerix from India. Also see the sentimental analysis on Indian investors investing in Chimerix. Get details on the Indian mutual funds that are investing in Chimerix. Get Analyst recommendations and forecasts along with all the Chimerix's financials.

Chimerix share price movements

  • Today's Low: $3.05
    Today's High: $3.38

    Day's Volatility :9.63%

  • 52 Weeks Low: $0.75
    52 Weeks High: $3.39

    52 Weeks Volatility :77.88%

Chimerix Returns

PeriodChimerix IncSector (Health Care)Index (Russel 2000)
3 Months
269.67%
-9.0%
0.0%
6 Months
275.66%
-4.6%
0.0%
1 Year
252.51%
3.0%
0.0%
3 Years
-51.1%
0.0%
-21.1%

Chimerix Key Statistics

in dollars & INR

Previous Close
$3.02
Open
$3.07
Today's High
$3.375
Today's Low
$3.05
Market Capitalization
$300.4M
Today's Volume
$1.6M
52 Week High
$3.39
52 Week Low
$0.75
Revenue TTM
$159.0K
EBITDA
$-92.7M
Earnings Per Share (EPS)
$-0.94
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-48.59%

How to invest in Chimerix from India?

It is very easy for Indian residents to invest directly in Chimerix from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Chimerix stock in both Indian Rupees (INR) and US Dollars (USD). Search for Chimerix or CMRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Chimerix or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Chimerix shares which would translate to 0.255 fractional shares of Chimerix as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Chimerix, in just a few clicks!

Returns in Chimerix for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Chimerix investment value today

Current value as on today

₹3,53,818

Returns

₹2,53,818

(+253.82%)

Returns from Chimerix Stock

₹2,51,579 (+251.58%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Chimerix

27600.0%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Chimerix from India has grown in the last 30 days as on Dec 26, 2024. 27600.0% more purchase transactions for Chimerix in the last 30 days versus the previous period.

286%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Chimerix on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 286% more investors are searching Chimerix in the last 30 days versus the previous period.

Global Institutional Holdings in Chimerix

  • RA Capital Management, LLC

    9.78%

  • Vanguard Group Inc

    4.82%

  • Monaco Asset Management

    4.69%

  • Millennium Management LLC

    2.66%

  • Armistice Capital, LLC

    2.46%

  • Vestal Point Capital LP

    1.56%

Analyst Recommendation on Chimerix

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Chimerix(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Chimerix

What analysts predicted

Upside of 151.5%

Current:

$3.34

Target:

$8.40

Insights on Chimerix

  • Price Movement

    In the last 1 month, CMRX stock has moved up by 269.4%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 129.0K → 26.0K (in $), with an average decrease of 79.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -20.68M → -22.87M (in $), with an average decrease of 10.6% per quarter
  • CMRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 78.7%

Chimerix Technicals Summary

Sell

Neutral

Buy

Chimerix is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Chimerix Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Chimerix Inc
269.43%
275.66%
252.51%
-51.1%
64.53%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Chimerix Inc
0.48
NA
0.0
-1.0
-0.49
-0.3
NA
1.51
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Chimerix Inc
Buy
$300.4M
64.53%
0.48
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Chimerix

led by an experienced antiviral drug development team, chimerix is developing novel oral antiviral therapeutics with the potential to improve quality of life for patients in multiple settings, including transplant, oncology, acute care and global health. the company’s proprietary lipid technology has given rise to two clinical stage compounds, cmx001 and cmx157, which have demonstrated the potential for enhanced activity, bioavailability and safety compared to currently approved drugs. chimerix’s lead compound, cmx001, is a broad spectrum lipid acyclic nucleoside phosphonate that inhibits double-stranded dna (dsdna) viruses including cytomegalovirus (cmv), adenovirus, bk virus, herpes simplex virus and variola (smallpox). cmx001 has completed phase 2 clinical development for the prophylaxis of cmv and is in phase 2 development for the preemption and treatment of adenovirus infection in hematopoietic stem cell transplant (hsct) recipients. to date, more than 750 patients have been dosed
Organization
Chimerix
Employees
72
CEO
Mr. Michael T. Andriole M.B.A.
Industry
Health Technology

Management People of Chimerix

NameTitle
Mr. Michael T. Andriole M.B.A.
CEO, President & Director
Dr. Michael A. Alrutz J.D., Ph.D.
Senior VP, General Counsel & Corporate Secretary
Dr. Allen S. Melemed M.B.A., M.D.
Chief Medical Officer
Ms. Michelle LaSpaluto
Chief Financial Officer
Mr. Thomas J. Riga
Chief Operating & Commercial Officer
Mr. David Jakeman CPA
Vice President of Accounting & Finance
Dr. Joshua E. Allen Ph.D.
Chief Scientific Officer
Dr. Roy W. Ware M.B.A., Ph.D.
Chief Manufacturing Technology Officer

Important FAQs about investing in Chimerix from India :

What is Chimerix share price today?

Chimerix share price today stands at $3.34, Open: $3.07 ; Previous Close: $3.02 ; High: $3.38 ; Low: $3.05 ; 52 Week High: $3.39 ; 52 Week Low: $0.75. The stock opens at $3.07, after a previous close of $3.02. The stock reached a daily high of $3.38 and a low of $3.05, with a 52-week high of $3.39 and a 52-week low of $0.75.

Can Indians buy Chimerix shares?

Yes, Indians can invest in the Chimerix (CMRX) from India.

With INDmoney, you can buy Chimerix at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Chimerix at zero transaction cost.

How can I buy Chimerix shares from India?

It is very easy to buy Chimerix from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Chimerix be purchased?

Yes, you can buy fractional shares of Chimerix with INDmoney app.

What are the documents required to start investing in Chimerix stocks?

To start investing in Chimerix, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Chimerix

Today’s highest price of Chimerix (CMRX) is $3.38.

Today’s lowest price of Chimerix (CMRX) is $3.05.

What is today's market capitalisation of Chimerix

Today's market capitalisation of Chimerix CMRX is 300.4M

What is the 52 Week High and Low Range of Chimerix

  • 52 Week High

    $3.39

  • 52 Week Low

    $0.75

What are the historical returns of Chimerix?

  • 1 Month Returns

    269.43%

  • 3 Months Returns

    275.66%

  • 1 Year Returns

    252.51%

  • 5 Years Returns

    64.53%

Who is the Chief Executive Officer (CEO) of Chimerix

Mr. Michael T. Andriole M.B.A. is the current Chief Executive Officer (CEO) of Chimerix.